OGN Organon & Co.

Did the company actually spend money buying back stock in 3+ of the last 4 quarters?

Not enough buyback data

Is the most recent quarter's buyback spend more than 15% above the trailing average?

Not enough buyback data

What percentage of free cash flow is going to buybacks? Bull: 30-80%. Bear: <10% or >80%.

Missing buyback or cash flow data

How fast are they shrinking the float? Bull: 2%+ annually. Bear: under 0.5%.

Missing shares repurchased or outstanding data

Are officers and directors buying stock with their own money on the open market?

6 open-market purchases by 5 insiders

• COX CARRIE SMITH (Executive Chair) bought 65,400 shares at $7.67 on 2025-11-12
• COX CARRIE SMITH () bought 12,469 shares at $8.07 on 2025-05-14
• Falcione Aaron (Chief Human Resources Officer) bought 5,500 shares at $8.77 on 2025-05-07
• Weaver Kirke (Gen. Counsel & Corp. Secy.) bought 8,045 shares at $9.21 on 2025-05-06
• Karp Daniel (Executive VP, Corp. Dev.) bought 3,500 shares at $8.24 on 2025-05-06
• WALSH MATTHEW M (Chief Financial Officer) bought 11,400 shares at $8.82 on 2025-05-05

Are insider purchases happening during the same quarters the company is actively buying back stock?

Need both buyback and insider purchase data

Looking at all open-market transactions, are insiders net buyers or net sellers?

Insiders bought $1M, sold $0M (net buying)

Active buyback + insiders net selling 3x+ more than buying. Company cash may be supporting price while insiders exit.

No buyback-insider divergence detected